Skye Bioscience, Inc. - 10-Q Filing
Skye Bioscience reports Q3 2026 results with 4,423,469 shares of common stock outstanding as of November 10, 2026.
Tickers: $SKYE
More Regulatory news
- Andersen Group Inc. - 8-K Filing
- AltEnergy Acquisition Corp - 10-Q Filing
- AtlasClear Holdings, Inc. - 10-Q Filing
- Amerant Bancorp Inc. - 8-K Filing
- iShares Gold Trust Micro - 8-K Filing
- iShares Silver Trust - 8-K Filing
- ISHARES GOLD TRUST - 8-K Filing
- Tradewinds Universal - 8-K Filing
- iShares Bitcoin Trust ETF - 8-K Filing
- iShares S&P GSCI Commodity-Indexed Trust - 8-K Filing